Validation of prognostic scores for survival in cancer patients beyond first-line therapy
<p>Abstract</p> <p>Background</p> <p>We aimed to validate prognostic scores for survival in patients undergoing chemotherapy for advanced or metastatic cancer after first-line treatment.</p> <p>Methods</p> <p>We previously described two models wi...
Main Authors: | Quiblier Florent, Saba Chadi, Pérol David, Chabaud Sylvie, Bajard Agathe, Rebattu Paul, Chvetzoff Gisèle, Ray-Coquard Isabelle, Trédan Olivier, Blay Jean-Yves, Bachelot Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/95 |
Similar Items
-
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
by: Ismaili Mohammed, et al.
Published: (2010-06-01) -
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial
by: Pérol David, et al.
Published: (2012-12-01) -
Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond
by: Axel de Bernardi, et al.
Published: (2022-02-01) -
Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
by: Isabelle Ray-Coquard, et al.
Published: (2020-11-01) -
Molecular Mechanisms of Kaposi Sarcoma Development
by: Andy Karabajakian, et al.
Published: (2022-04-01)